| Asset | 30 Sep 2026 | 31 Aug 2026 | 31 Jul 2026 | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 |
|---|---|---|---|---|---|---|
| Equity | 100.14% | 100.13% | 100.03% | 100.06% | 100.09% | 100.08% |
| Debt | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Others (incl. cash) | -0.14% | -0.13% | -0.03% | -0.06% | -0.09% | -0.08% |
| Commodities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Real Estate | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Instrument | Sector | No. of Shares | Value (Rs. Cr) | Weight | Change |
|---|---|---|---|---|---|
| Laurus Labs Ltd. | Healthcare | 1,31,927 | 26.12 | 11.84% | 0.62%↑ |
| Lupin Ltd. | Healthcare | 82,281 | 16.7 | 7.57% | -0.44%↓ |
| Aurobindo Pharma Ltd. | Healthcare | 93,615 | 15.65 | 7.09% | -0.07%↓ |
| Fortis Healthcare Ltd. | Healthcare | 1,76,499 | 13.59 | 6.16% | -0.96%↓ |
| Glenmark Pharmaceuticals Ltd. | Healthcare | 51,001 | 11.91 | 5.40% | -0.22%↓ |
| Alkem Laboratories Ltd. | Healthcare | 20,425 | 10.55 | 4.78% | 0.08%↑ |
| Mankind Pharma Ltd. | Healthcare | 38,387 | 9.61 | 4.36% | 0.23%↑ |
| Ipca Laboratories Ltd. | Healthcare | 47,059 | 9.07 | 4.11% | -0.02%↓ |
| Biocon Ltd. | Healthcare | 2,36,076 | 8.74 | 3.96% | -0.47%↓ |
| Gland Pharma Ltd. | Healthcare | 26,996 | 7.83 | 3.55% | 0.09%↑ |
| Sai Life Sciences Ltd. | Healthcare | 46,851 | 7.14 | 3.24% | 0.21%↑ |
| Krishna Institute of Medical Sciences Ltd | Healthcare | 90,397 | 6.75 | 3.06% | 0.11%↑ |
| Aster DM Quality Care Ltd. | Healthcare | 90,546 | 6.31 | 2.86% | -0.02%↓ |
| Neuland Laboratories Ltd. | Healthcare | 2,921 | 6.24 | 2.83% | -0.16%↓ |
| Wockhardt Ltd. | Healthcare | 27,982 | 5.92 | 2.68% | 0.34%↑ |
| Acutaas Chemicals Ltd. | Healthcare | 17,578 | 5.76 | 2.61% | 0.14%↑ |
| Ajanta Pharma Ltd. | Healthcare | 15,443 | 5.59 | 2.53% | 0.24%↑ |
| Dr. Lal Pathlabs Ltd. | Healthcare | 26,429 | 5.25 | 2.38% | 0.11%↑ |
| Abbott India Ltd. | Healthcare | 1,765 | 4.79 | 2.17% | 0.14%↑ |
| Piramal Pharma Ltd. | Healthcare | 2,10,417 | 4.35 | 1.97% | -0.04%↓ |
| Sector | 30 Sep 2026 | 31 Aug 2026 | 31 Jul 2026 | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 |
|---|---|---|---|---|---|---|
| Healthcare | 100.14% | 100.13% | 100.03% | 100.06% | 100.09% | 100.08% |
28.5 / 100
Weighted average Value score is 28.5. This indicates that portfolio is relatively reasonably valued using composite of value measures.
66.2 / 100
Weighted average Price Momentum score is 66.2. This indicates that portfolio has average momentum using composite of momentum measures.
79.1 / 100
Weighted average Quality score is 79.1. This indicates that portfolio has high quality using composite of quality measures.
65.0 / 100
Weighted average QVM score is 65.0. This indicates that portfolio has average QVM score and hence a neutral stance is warranted.
